Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fausto Germano-Neto"'
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study
Autor:
Rui M B Maciel, Cleber P Camacho, Lígia V M Assumpção, Natassia E Bufalo, André L Carvalho, Gisah A de Carvalho, Luciana A Castroneves, Francisco M de Castro Jr, Lucieli Ceolin, Janete M Cerutti, Rossana Corbo, Tânia M B L Ferraz, Carla V Ferreira, M Inez C França, Henrique C R Galvão, Fausto Germano-Neto, Hans Graf, Alexander A L Jorge, Ilda S Kunii, Márcio W Lauria, Vera L G Leal, Susan C Lindsey, Delmar M Lourenço Jr, Léa M Z Maciel, Patrícia K R Magalhães, João R M Martins, M Cecília Martins-Costa, Gláucia M F S Mazeto, Anelise I Impellizzeri, Célia R Nogueira, Edenir I Palmero, Cencita H C N Pessoa, Bibiana Prada, Débora R Siqueira, Maria Sharmila A Sousa, Rodrigo A Toledo, Flávia O F Valente, Fernanda Vaisman, Laura S Ward, Shana S Weber, Rita V Weiss, Ji H Yang, Magnus R Dias-da-Silva, Ana O Hoff, Sergio P A Toledo, Ana L Maia
Publikováno v:
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstr
Externí odkaz:
https://doaj.org/article/37d0d78e06b24b48bb6c7725c95f14cc
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study
Autor:
Léa Maria Zanini Maciel, Carla Vaz Ferreira, Sergio P. A. Toledo, Flávia O. F. Valente, Luciana A. Castroneves, Rui M. B. Maciel, Gisah Amaral de Carvalho, Rita V Weiss, Janete M. Cerutti, Henrique de Campos Reis Galvão, Tânia M B L Ferraz, Célia Regina Nogueira, Patrícia Künzle Ribeiro Magalhães, Francisco M de Castro, Shana de Souto Weber, Vera L.G. Leal, Cencita H. C. N. Pessoa, M Inez C França, Natassia Elena Bufalo, Gláucia Maria Ferreira da Silva Mazeto, Maria A. Sousa, Ji H. Yang, Bibiana Prada, Débora Rodrigues Siqueira, M Cecília Martins-Costa, Magnus R. Dias-da-Silva, Rossana Corbo, João Roberto Maciel Martins, Ana Luiza Maia, Ana O. Hoff, Delmar M. Lourenço, Laura Sterian Ward, Edenir Inêz Palmero, Hans Graf, Marcio W Lauria, Rodrigo A. Toledo, Alexander A. L. Jorge, Ligia V. M. Assumpção, Anelise I Impellizzeri, Ilda S. Kunii, Fernanda Vaisman, Lucieli Ceolin, Fausto Germano-Neto, André Lopes Carvalho, Susan C. Lindsey, Cleber P. Camacho
Publikováno v:
Endocrine Connections
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce317c959d2774e9d3360c02699a4a69
https://pubmed.ncbi.nlm.nih.gov/30763276
https://pubmed.ncbi.nlm.nih.gov/30763276
Autor:
Rosa Paula M. Biscolla, Maria Conceição Mamone, Susan C. Lindsey, Rui M. B. Maciel, R. M. Tuttle, Magnus R. Dias-da-Silva, Fabio Brodskyn, Cleber P. Camacho, Alberto L. Machado, Fausto Germano-Neto, Flávia O. F. Valente, Ji H. Yang
Publikováno v:
Clinical Endocrinology. 83:938-942
Objective Staging systems applied to medullary thyroid cancer (MTC) rely on initial clinical and pathological features and do not consider the response to treatment. To determine whether MTC staging can be improved by incorporating the first postoper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d954ee1f3d66e73ad982afe523f051f0
https://doi.org/10.1111/cen.12657
https://doi.org/10.1111/cen.12657
Autor:
Flávia O. F. Valente, Janete M. Cerutti, Rosa Paula M. Biscolla, Magnus R. Dias-da-Silva, Cleber P. Camacho, Rui M. B. Maciel, Maria Clara C. Melo, Thiago R.N. Lima, José Gilberto H. Vieira, Susan C. Lindsey, Ji H. Yang, Fausto Germano-Neto
Publikováno v:
Thyroid. 23:308-316
Serum calcitonin (sCT) is the main tumor marker for medullary thyroid cancer (MTC), but it has certain limitations. Various sCT assays may have important intra-assay or interassay variation and may yield different and sometimes conflicting results. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2354036d59abc44302aed115d59d23e4
https://doi.org/10.1089/thy.2012.0361
https://doi.org/10.1089/thy.2012.0361
Autor:
Misaki Y. Sittoni, Priscila S. Signorini, Cleber P. Camacho, Flávia O. F. Valente, Ji H. Yang, Magnus R. Dias-da-Silva, Susan C. Lindsey, Janete M. Cerutti, Ilda S. Kunii, Fausto Germano-Neto, Rui M. B. Maciel, Rosana Delcelo
Publikováno v:
Hormonescancer. 3(4)
RET sequencing has become an important tool in medullary thyroid cancer (MTC) evaluation and should be performed even in the absence of family history of MTC. The most commonly studied exons in index cases are 8, 10, 11, and 13–16. To address the A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d5a0e77c578074a7a1b86baa75d8f0
https://pubmed.ncbi.nlm.nih.gov/22648435
https://pubmed.ncbi.nlm.nih.gov/22648435